| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000237903.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008496031 |
Sensitive |
| ENSG00000237903.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042135689 |
Sensitive |
| ENSG00000237903.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043270796 |
Resistant |
